Mustang Bio, Inc. (MBIO) Financials
MBIO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 17.7 million | 17.6 million |
2023-09-30 | 20.6 million | 16.6 million |
2023-06-30 | 29.1 million | 15.4 million |
2023-03-31 | 73.6 million | 43.8 million |
MBIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -7.3 million | 188000 |
2023-09-30 | -12.1 million | 100000 |
2023-06-30 | -12.4 million | 45000 |
2023-03-31 | -17.8 million | 235000 |
MBIO Net Income
No data available :(
MBIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 6.2 million | - | 2.5 million |
2023-09-30 | 9.6 million | - | 2.6 million |
2023-06-30 | 15.4 million | - | 2.6 million |
2023-03-31 | 58.1 million | 27.6 million | 3.9 million |
MBIO Shares Outstanding
MBIO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 30000 | 6.4 million | 2.2 million | 79000 |
2023-09-30 | 50000 | 9.5 million | 2.1 million | - |
2023-06-30 | 34000 | 10.8 million | 3.1 million | - |
2023-03-31 | 18000 | 14.0 million | 2.3 million | - |
MBIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 363000 |
2023-09-30 | - | 1.4 million |
2023-06-30 | - | 698000 |
2023-03-31 | - | 858000 |
MBIO
Price: $0.32
52 week price:
Earnings Per Share: -6.00 USD
P/E Ratio: -0.15
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 169948
Ebitda: -6.9 millionMarket Capitalization: 5.3 million